Artiva Biotherapeutics, Inc. — All Filings
146 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-100294 | Mar 10, 2026 | — |
| S-8 | S-8 | 0001193125-26-100245 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001193125-26-100135 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-100131 | Mar 10, 2026 | — |
| 3 | 3 | 0001193125-26-067518 | Feb 24, 2026 | Feb 18, 2026 |
| 8-K | 8-K | 0001193125-26-067509 | Feb 24, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-060074 | Feb 19, 2026 | Feb 18, 2026 |
| 3 | 3 | 0001193125-26-060069 | Feb 19, 2026 | Feb 18, 2026 |
| 8-K | 8-K | 0001193125-26-059716 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-057667 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057674 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057672 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057669 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057668 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-25-319696 | Dec 15, 2025 | — |
| 144 | — | 0001950047-25-010318 | Dec 15, 2025 | — |
| 4 | 4 | 0001193125-25-317983 | Dec 12, 2025 | — |
| 4 | 4 | 0001193125-25-317982 | Dec 12, 2025 | — |
| 4 | 4 | 0001193125-25-317981 | Dec 12, 2025 | — |
| 4 | 4 | 0001193125-25-317980 | Dec 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-317784 | Dec 12, 2025 | Dec 10, 2025 |
| 4 | 4 | 0001193125-25-285009 | Nov 17, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-285008 | Nov 17, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-285006 | Nov 17, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-285005 | Nov 17, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-285004 | Nov 17, 2025 | Nov 15, 2025 |
| 144 | — | 0001950047-25-008956 | Nov 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-275902 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-275872 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-275867 | Nov 12, 2025 | — |
| 4 | — | 0001909362-25-000004 | Oct 17, 2025 | — |
| 144 | — | 0001950047-25-008048 | Oct 17, 2025 | — |
| 4 | — | 0001415889-25-022224 | Aug 18, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-022223 | Aug 18, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-022222 | Aug 18, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-022221 | Aug 18, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-022220 | Aug 18, 2025 | May 15, 2025 |
| EFFECT | — | 9999999995-25-002641 | Aug 15, 2025 | — |
| 144 | — | 0001950047-25-005893 | Aug 15, 2025 | — |
| CORRESP | — | 0001193125-25-180011 | Aug 13, 2025 | — |
| UPLOAD | — | 0000000000-25-008421 | Aug 11, 2025 | — |
| S-3 | S-3 | 0001193125-25-174570 | Aug 6, 2025 | — |
| S-8 | S-8 | 0000950170-25-104097 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104045 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104028 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002480 | Jul 16, 2025 | — |
| 4 | — | 0001415889-25-018284 | Jun 26, 2025 | Jun 24, 2025 |
| 4 | — | 0001415889-25-018279 | Jun 26, 2025 | Jun 24, 2025 |
| 4 | — | 0001415889-25-018278 | Jun 26, 2025 | Jun 24, 2025 |
| 4 | — | 0001415889-25-018277 | Jun 26, 2025 | Jun 24, 2025 |